Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIOngoingFeb 18, 2026Oxycodone Hydrochloride TabletsDefective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.Amerisource Health Services LLC · D-0338-2026Class IIOngoingFeb 18, 2026vancomycin HClLack of Assurance of SterilityFresenius Kabi Compounding, LLC · D-0337-2026Class IIOngoingFeb 18, 2026vancomycin HClLack of Assurance of SterilityFresenius Kabi Compounding, LLC · D-0336-2026Class IIOngoingFeb 18, 2026thiamine HClLack of Assurance of SterilityFresenius Kabi Compounding, LLC · D-0335-2026Class IIOngoingFeb 18, 2026ketamine HClLack of Assurance of SterilityFresenius Kabi Compounding, LLC · D-0334-2026Class IIOngoingFeb 18, 2026acyclovir sodiumLack of Assurance of SterilityFresenius Kabi Compounding, LLC · D-0333-2026Class IIOngoingFeb 18, 2026Testosterone 100mg Anastrozole 4mgPresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0331-2026Class IIOngoingFeb 18, 2026Testosterone 87.5mgPresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0330-2026Class IIOngoingFeb 18, 2026Testosterone 200mgPresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0329-2026Class IIOngoingFeb 18, 2026Testosterone 100mgPresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0328-2026Class IIOngoingFeb 18, 2026Testosterone 75mgPresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0327-2026Class IIOngoingFeb 18, 2026Testosterone 100mgPresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0326-2026Class IIOngoingFeb 18, 2026TestosteronePresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0325-2026Class IIOngoingFeb 18, 2026TestosteronePresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0324-2026Class IIOngoingFeb 18, 2026TestosteronePresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0323-2026Class IIOngoingFeb 18, 2026TestosteronePresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0322-2026Class IIOngoingFeb 18, 2026TestosteronePresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0321-2026Class IIOngoingFeb 18, 2026TestosteronePresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0320-2026Class IIOngoingFeb 18, 2026TestosteronePresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0319-2026Class IIOngoingFeb 18, 2026TestosteronePresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0318-2026Class IIOngoingFeb 18, 2026TestosteronePresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0317-2026Class IIOngoingFeb 18, 2026TestosteronePresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0316-2026Class IIOngoingFeb 18, 2026ESTRADIOLPresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0315-2026Class IIOngoingFeb 18, 2026ESTRADIOLPresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0314-2026Class IIOngoingFeb 18, 2026ESTRADIOLPresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0313-2026Class IIOngoingFeb 18, 2026ESTRADIOLPresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0312-2026Class IIOngoingFeb 18, 2026ESTRADIOLPresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0311-2026Class IIOngoingFeb 18, 2026ESTRADIOLPresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0310-2026Class IIOngoingFeb 18, 2026ESTRADIOLPresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0309-2026Class IIOngoingFeb 18, 2026ESTRADIOLPresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0308-2026Class IIOngoingFeb 18, 2026ESTRADIOLPresence of Foreign substance - potential presence of metal particulate matterF.H. INVESTMENTS, Inc. (dba Asteria Health) · D-0307-2026Class IIIOngoingFeb 18, 2026Doxazosin TabletsTablets/Capsules Imprinted with Wrong IDUnichem Pharmaceuticals USA Inc. · D-0306-2026Class IIOngoingFeb 18, 2026Pro Numb Tattoo Numbing SpraycGMP deviationsPro Numb Tattoo Numbing Spray LLC · D-0303-2026Class IIOngoingFeb 18, 2026Pro Numb Tattoo Numbing SpraycGMP deviationsPro Numb Tattoo Numbing Spray LLC · D-0302-2026Class IIOngoingFeb 11, 2026Diclofenac SodiumFailed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.Sun Pharmaceutical Industries Inc · D-0342-2026Class IOngoingFeb 11, 2026Rheumacare capsulesCGMP Deviations: product found to contain lead.Handelnine Global LLC · D-0332-2026Class IIOngoingFeb 11, 2026Trazodone HydrochloridePresence of Foreign Tablets/CapsulesGranules Pharmaceuticals Inc. · D-0305-2026Class IOngoingFeb 11, 2026Green Lumber Natural Fuel For Men capsuleMarketed without an Approved NDA/ANDA: FDA analysis found this product to contain tadalafilGreen Lumber Holdings, LLC · D-0304-2026Class IIOngoingFeb 11, 2026Bisoprolol Fumarate and Hydrochlorothiazide tabletscGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.Unichem Pharmaceuticals USA Inc. · D-0301-2026Class IIIOngoingFeb 4, 2026Glycopyrrolate Oral SolutionFailed Impurities/Degradation SpecificationsNovadoz Pharmaceuticals LLC · D-0300-2026